From October 1, 2023 to December 31, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 188,029 shares, representing 1.28% for $5 million under the buyback announced on April 13, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.65 USD | -0.35% | -1.08% | +13.20% |
May. 30 | Caligan Partners Enters into a Cooperation Agreement with Anika Therapeutics | CI |
May. 28 | Anika Therapeutics Approves $40 Million Share Repurchase Program | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.20% | 382M | |
+1.90% | 94.22B | |
-4.08% | 37.76B | |
-13.26% | 32.5B | |
+73.38% | 27.75B | |
-11.58% | 16.13B | |
-1.66% | 14.19B | |
-11.67% | 11.42B | |
+190.36% | 11.06B | |
-52.61% | 9.09B |
- Stock Market
- Equities
- ANIK Stock
- News Anika Therapeutics, Inc.
- Tranche Update on Anika Therapeutics, Inc.'s Equity Buyback Plan announced on April 13, 2023.